×

Vertex soars on cystic fibrosis innovation

10:54 AM ET Tue, 24 June 2014

CNBC's Meg Tirrell reports Vertex Pharmaceuticals' cystic fibrosis combination of Kalydeco and Lumacaftor has expanded their patient population.